Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90.
Published October 3, 2012 · Recall initiated: July 19, 2012
Summary
FDA records drug Class II recall D-1695-2012, published October 3, 2012 and initiated July 19, 2012. Recalling firm: Abbott Laboratories; Status: Terminated; Reported quantity: 42,596 Bottles; Lot: Lot: 18353A8, Exp 08/31/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if SYNTHROID has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SYNTHROID
- Manufacturer
- Abbott Laboratories
- Distributor
- Nationwide
- UPC
- 0300747149902
- Lot
- Lot: 18353A8, Exp 08/31/2013
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASynthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. NorthNovember 15, 2023
- FDASynthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90;January 9, 2013
- FDASynthroid (levothyroxine sodium) Tablets USP, 50 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, NorthOctober 3, 2012
- FDASynthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, NorthOctober 3, 2012
- FDAFentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcoholOctober 3, 2012
- FDAVecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder perOctober 3, 2012
Questions about this recall
Was Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90. recalled?
Yes. FDA published recall D-1695-2012 on October 3, 2012. Reported hazard: Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SYNTHROID. UPC: 0300747149902.